Impaired neutrophils in children with the typical form of hemolytic uremic syndrome

Pediatric Nephrology

Volumn 20, Issue 9, 2005, Pages 1306-1314

  Fernández, Gabriela C ^a   Gómez, Sonia A ^a   Rubel, Carolina J ^a   Bentancor, Leticia V ^a   Barrionuevo, Paula ^a   Alduncín, Marta ^b   Grimoldi, Irene ^b   Exeni, Ramón ^b   Isturiz, Martín A ^a   Palermo, Marina S ^a  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

^b Hosp Munic de Ninos de S Justo   (Argentina)

Author keywords

Cytokines; D+HUS; Patients; PMN; ROS generation

Indexed keywords

CYTOKINE; PROTEINASE; REACTIVE OXYGEN METABOLITE; SHIGA TOXIN;

ARTICLE; BLOOD SAMPLING; CELL GRANULE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGRANULATION; ENDOTHELIUM INJURY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IN VITRO STUDY; INFANT; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; PATHOPHYSIOLOGY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL;

CELL DEGRANULATION; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PEPTIDE HYDROLASES; REACTIVE OXYGEN SPECIES;

EID: 24044441274     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1906-9     Document Type: Article

References (32)

1. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H (1985) The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151:775-782 1:STN:280:BiqC1cvgvVA%3D
2. Remuzzi G, Ruggenenti P (1995) The hemolytic uremic syndrome. Kidney Int 48:2-19 1:STN:280:BymD383otFA%3D
3. Paton JC, Paton AW (1998) Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450-479 1:STN:280:DyaK1czjtlKlug%3D%3D
4. Keusch GT, Acheson DW (1997) Thrombotic thrombocytopenic purpura associated with Shiga toxins. Semin Hematol 34:106-116 1:CAS:528:DyaK2sXivVGnsbo%3D
5. Milford D, Taylor CM, Rafaat F, Halloran E, Dawes J (1989) Neutrophil elastases and haemolytic uraemic syndrome. Lancet 2:1153 10.1016/ S0140-6736(89)91512-2
6. Fitzpatrick MM, Shah V, Filler G, Dillon MJ, Barratt TM (1992) Neutrophil activation in the haemolytic uraemic syndrome: Free and complexed elastase in plasma. Pediatr Nephrol 6:50-53 10.1007/BF00856833
7. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365-376 1:CAS:528:DyaL1MXhtleiu7Y%3D
8. Lentsch AB, Ward PA (2000) Regulation of inflammatory vascular damage. J Pathol 190:343-348 10.1002/ (SICI)1096-9896(200002)190:3<343::AID-PATH522>3.0.CO;2-M
9. Sengelov H, Kjeldsen L, Borregaard N (1993) Control of exocytosis in early neutrophil activation. J Immunol 150:1535-1543 1:STN:280:ByyC28zlvVQ%3D
10. Borregaard N, Cowland JB (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503-3521 1:CAS:528:DyaK2sXjt12nsrc%3D
11. Fernandez GC, Rubel C, Barrionuevo P, Lopez L, Ramirez F, Diaz M, Isturiz MA, Palermo MS (2002) Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome. Pediatr Nephrol 17:337-344 10.1007/s00467-002-0832-3
12. Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET (1973) The hemolytic-uremic syndrome. Nephron 11:174-192 1:STN:280:CSuD383mvVU%3D
13. Knapp W, Strobl H, Majdic O (1994) Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 18:187-198 1:STN:280:ByqB3czgtVY%3D
14. Rubel C, Fernandez GC, Rosa FA, Gomez S, Bompadre MB, Coso OA, Isturiz MA, Palermo MS (2002) Soluble fibrinogen modulates neutrophil functionality through the activation of an extracellular signal-regulated kinase-dependent pathway. J Immunol 168:3527-3535 1:CAS:528:DC%2BD38Xis1ajtLk%3D
15. Duner KI (1993) A new kinetic single-stage Limulus amoebocyte lysate method for the detection of endotoxin in water and plasma. J Biochem Biophys Methods 26:131-142 10.1016/0165-022X(93)90043-N
16. te Loo DM, Monnens LA, van Der Velden TJ, Vermeer MA, Preyers F, Demacker PN, van Den Heuvel LP, van Hinsbergh VW (2000) Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95:3396-3402 10828021
17. Palermo MS, Alves Rosa MF, Van Rooijen N, Isturiz MA (1999) Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model. Clin Exp Immunol 116:462-467 10.1046/ j.1365-2249.1999.00925.x
18. Rosenbloom AJ, Pinsky MR, Napolitano C, Nguyen TS, Levann D, Pencosky N, Dorrance A, Ray BK, Whiteside T (1999) Suppression of cytokine-mediated beta2-integrin activation on circulating neutrophils in critically ill patients. J Leukoc Biol 66:83-89 1:CAS:528:DyaK1MXksFequrs%3D
19. Rodeberg DA, Bass RC, Alexander JW, Warden GD, Babcock GF (1997) Neutrophils from burn patients are unable to increase the expression of CD11b/CD18 in response to inflammatory stimuli. J Leukoc Biol 61:575-582 1:CAS:528:DyaK2sXivVOisr8%3D
20. Vaissiere C, Le Cabec V, Maridonneau-Parini I (1999) NADPH oxidase is functionally assembled in specific granules during activation of human neutrophils. J Leukoc Biol 65:629-634 1:CAS:528:DyaK1MXjtFGhtrw%3D
21. Borregaard N, Heiple JM, Simons ER, Clark RA (1983) Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: Translocation during activation. J Cell Biol 97:52-61 10.1083/jcb.97.1.52
22. Karlsson A, Dahlgren C (2002) Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal 4:49-60 10.1089/152308602753625852
23. Sassetti B, Vizcarguenaga MI, Zanaro NL, Silva MV, Kordich L, Florentini L, Diaz M, Vitacco M, Sanchez Avalos JC (1999) Hemolytic uremic syndrome in children: Platelet aggregation and membrane glycoproteins. J Pediatr Hematol Oncol 21:123-128 10.1097/00043426-199903000-00008
24. Cohen G, Haag-Weber M, Horl WH (1997) Immune dysfunction in uremia. Kidney Int Suppl 62:S79-82 1:STN:280:DyaK1c%2FhtFOqsg%3D%3D
25. Cohen G, Rudnicki M, Walter F, Niwa T, Horl WH (2001) Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes. J Am Soc Nephrol 12:1264-1271 1:CAS:528:DC%2BD3MXktlyjsbo%3D
26. Wagner JG, Roth RA (1999) Neutrophil migration during endotoxemia. J Leukoc Biol 66:10-24 1:CAS:528:DyaK1MXksFeqtbk%3D
27. Burtnick LD (1984) Modification of actin with fluorescein isothiocyanate. Biochim Biophys Acta 791:57-62 1:CAS:528:DyaL2MXhvF2ntQ%3D%3D
28. Miller L, Phillips M, Reisler E (1988) Polymerization of actin modified with fluorescein isothiocyanate. Eur J Biochem 174:23-29 10.1111/ j.1432-1033.1988.tb14057.x
29. Favazza M, Lerho M, Houssier C (1990) Labelling of histone H5 and its interaction with DNA. 1. Histone H5 labelling with fluorescein isothiocyanate. J Biomol Struct Dyn 7:1291-1300 1:CAS:528:DyaK3cXkvFChsrk%3D
30. Johnson DA, Taylor P (1982) Site-specific fluorescein-labeled cobra alpha-toxin. Biochemical and spectroscopic characterization. J Biol Chem 257:5632-5636
31. Hentz NG, Richardson JM, Sportsman JR, Daijo J, Sittampalam GS (1997) Synthesis and characterization of insulin-fluorescein derivatives for bioanalytical applications. Anal Chem 69:4994-5000 10.1021/ac970726m
32. Fong JS, Kaplan BS (1982) Impairment of platelet aggregation in hemolytic uremic syndrome: Evidence for platelet "exhaustion". Blood 60:564-570 1:STN:280:Bi2B2MjntFA%3D